Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32


Food for thought on hepatocellular carcinoma.

Fang M, Yao M, Wang L, Yao DF.

Hepatobiliary Pancreat Dis Int. 2019 Apr 24. pii: S1499-3872(19)30085-2. doi: 10.1016/j.hbpd.2019.04.010. [Epub ahead of print] No abstract available.


High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.

Zheng W, Yang J, Dong Z, Wang L, Fang M, Wu W, Yao D, Yao M.

Cancer Manag Res. 2018 Nov 20;10:5979-5989. doi: 10.2147/CMAR.S181742. eCollection 2018.


CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.

Yao M, Fang W, Smart C, Hu Q, Huang S, Alvarez N, Fields P, Cheng N.

Mol Cancer Res. 2019 Feb;17(2):604-617. doi: 10.1158/1541-7786.MCR-18-0750. Epub 2018 Nov 16.


Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy.

Wang L, Yao M, Zheng W, Fang M, Wu M, Sun J, Dong Z, Yao D.

Mini Rev Med Chem. 2019;19(4):272-280. doi: 10.2174/1389557518666181025151608. Review.


Role of secretory clusterin in hepatocarcinogenesis.

Yao M, Fang M, Zheng W, Dong Z, Yao D.

Transl Gastroenterol Hepatol. 2018 Aug 1;3:48. doi: 10.21037/tgh.2018.07.13. eCollection 2018. Review.


Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.

Zheng WJ, Yao M, Fang M, Wang L, Dong ZZ, Yao DF.

World J Gastroenterol. 2018 Aug 28;24(32):3650-3662. doi: 10.3748/wjg.v24.i32.3650.


SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.

Xiao N, Li H, Yu W, Gu C, Fang H, Peng Y, Mao H, Fang Y, Ni W, Yao M.

FASEB J. 2019 Jan;33(1):163-174. doi: 10.1096/fj.201800353R. Epub 2018 Jul 3.


Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.

Wang L, Yao M, Fang M, Zheng WJ, Dong ZZ, Pan LH, Zhang HJ, Yao DF.

Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):227-232. doi: 10.1016/j.hbpd.2018.03.005. Epub 2018 Mar 13.


Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.

Dong Z, Chen J, Yang X, Zheng W, Wang L, Fang M, Wu M, Yao M, Yao D.

Oncotarget. 2018 Jan 9;9(16):12705-12717. doi: 10.18632/oncotarget.24061. eCollection 2018 Feb 27.


GM-CSF ameliorates microvascular barrier integrity via pericyte-derived Ang-1 in wound healing.

Yan M, Hu Y, Yao M, Bao S, Fang Y.

Wound Repair Regen. 2017 Nov;25(6):933-943. doi: 10.1111/wrr.12608. Epub 2018 Feb 16.


Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.

Brummer G, Acevedo DS, Hu Q, Portsche M, Fang WB, Yao M, Zinda B, Myers M, Alvarez N, Fields P, Hong Y, Behbod F, Cheng N.

Mol Cancer Res. 2018 Feb;16(2):296-308. doi: 10.1158/1541-7786.MCR-17-0308. Epub 2017 Nov 13.


Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis.

Zhang Y, Li X, Fang S, Zhu Z, Yao M, Ying L, Zhu L, Ma Z, Wang W.

Mol Med Rep. 2017 Aug;16(2):1793-1800. doi: 10.3892/mmr.2017.6802. Epub 2017 Jun 19.


Beta-catenin can induce hair follicle stem cell differentiation into transit-amplifying cells through c-myc activation.

Shen Q, Yu W, Fang Y, Yao M, Yang P.

Tissue Cell. 2017 Feb;49(1):28-34. doi: 10.1016/j.tice.2016.12.005. Epub 2016 Dec 21.


MicroRNAs for osteosarcoma in the mouse: a meta-analysis.

Chang J, Yao M, Li Y, Zhao D, Hu S, Cui X, Liu G, Shi Q, Wang Y, Yang Y.

Oncotarget. 2016 Dec 20;7(51):85650-85674. doi: 10.18632/oncotarget.13333. Review.


Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma.

Yao M, Wang L, Fang M, Zheng W, Dong Z, Yao D.

Biosci Trends. 2016 Nov 15;10(5):337-343. Epub 2016 Oct 29. Review.


Substance P induces inflammatory responses involving NF-κB in genetically diabetic mice skin fibroblasts co-cultured with macrophages.

Ni T, Liu Y, Peng Y, Li M, Fang Y, Yao M.

Am J Transl Res. 2016 May 15;8(5):2179-88. eCollection 2016.


Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.

Fang WB, Yao M, Brummer G, Acevedo D, Alhakamy N, Berkland C, Cheng N.

Oncotarget. 2016 Aug 2;7(31):49349-49367. doi: 10.18632/oncotarget.9885.


TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.

Fang WB, Mafuvadze B, Yao M, Zou A, Portsche M, Cheng N.

PLoS One. 2015 Aug 7;10(8):e0135063. doi: 10.1371/journal.pone.0135063. eCollection 2015.


Polymorphisms of rs174616 in the FADS1-FADS2 gene cluster is associated with a reduced risk of type 2 diabetes mellitus in northern Han Chinese people.

Yao M, Li J, Xie T, He T, Fang L, Shi Y, Hou L, Lian K, Wang R, Jiang L.

Diabetes Res Clin Pract. 2015 Jul;109(1):206-12. doi: 10.1016/j.diabres.2015.03.009. Epub 2015 Mar 25.


Supplemental Content

Loading ...
Support Center